New Millennium Group’s Vicarious Surgical RBOT Stock Holding History

New Millennium Group’s Portfolio RBOT Stock Details RBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5	Closed	-$28	–	500
2025 Q3	$28	Buy	+5	New	+$38	﹤0.01%	480

Other funds holding RBOT

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

MAM

Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return

New Millennium Group's RBOT Position: Q4 2025 in Review

New Millennium Group sold out of Vicarious Surgical (RBOT) in Q4 2025, closing a stake of 5 shares — an estimated $28 sold.

New Millennium Group first reported a position in RBOT in Q3 2025 and held it in 1 quarter. The position peaked at $28 in Q3 2025. 36 funds tracked by Wall St. Rank hold RBOT as of Q4 2025.

New Millennium Group reported no remaining Vicarious Surgical position as of Q4 2025 after selling out during the quarter.
New Millennium Group sold 5 Vicarious Surgical shares in Q4 2025, an estimated $28.
New Millennium Group first reported a position in Vicarious Surgical in Q3 2025 and held it in 1 quarter.
New Millennium Group's Vicarious Surgical position peaked at $28 in Q3 2025.
36 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2025.

Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.